Trending...
- Wells Fargo Investment Institute Believes 2024 is a Pivotal Year for the Economy and Markets
- Emmy Award-Nominated Actor Ed Begley, Jr. To Receive 13th Annual Experience, Strength And Hope Award For His Recently Published Book: "To the Temple of Tranquility...And Step On It!: A Memoir"
- Unlocking the Magic of Miami Beach
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosciences, Inc. ("Enochian" or "the Company") (NASDAQ: ENOB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between January 17, 2018 and June 27, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before September 26, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Enochian co-founder Serhat Gumrukcu was not a licensed physician and did not hold a verifiable college degree of any type. The Company's science and technology, credited to Gumrukcu, were not likely to be legitimate. The Company overstated the commercial viability of its product pipeline. The Company's senior executives were aware of Gumrukcu's history including fraud. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Enochian, investors suffered damages.
More on The Californer
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Investors who purchased the Company's securities between January 17, 2018 and June 27, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before September 26, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
- New Hybrid Treatment Forces Cancer Cells to Starve
- LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that LivePerson, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- Biggest Christmas Book Giveaway By One Author Ever
- Tonight:"Season of Black Art" & San Francisco Black Film Festival Celebrate Black Film &Theatre
- Blueprint Medicines' Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH Annual Meeting
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Enochian co-founder Serhat Gumrukcu was not a licensed physician and did not hold a verifiable college degree of any type. The Company's science and technology, credited to Gumrukcu, were not likely to be legitimate. The Company overstated the commercial viability of its product pipeline. The Company's senior executives were aware of Gumrukcu's history including fraud. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Enochian, investors suffered damages.
More on The Californer
- Governor Newsom Highlights Funding for Climate Change Resiliency Projects Across California
- The Major Hope Foundation Brings 'A Major Day of Hope To Los Angeles'
- Blue Ridge Bankshares, Inc. (BRBS) Investor Notice: Robbins LLP Reminds Shareholders of Class Action Filed Against Blue Ridge Bankshares, Inc.
- California Gets $70 Million in Federal Funding to Accelerate Salton Sea Restoration
- California: Governor Newsom Announces Appointments 12.8.23
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Filed Under: Business
0 Comments
Latest on The Californer
- Neberon Heated Gloves: Your Best Winter Companion for Christmas
- Joby, ANA Holdings Partner with Nomura Real Estate Development for Vertiports in Japan
- Zero Upfront Fee Website- Thinking About Starting A Business?
- Penny S. Tee, MBA: A Beacon of Peace Amidst Conflict
- California: Governor Newsom Announces Appointments 12.7.23
- Habitat EJC Assembles National Team for Permanently Affordable Community
- State Marks 100+ Water System Consolidations, Providing Safe Drinking Water for 90,000 Californians
- Chaos Loc Releases New Album "Life After Super Max"
- Joel Osman is Promoted to Partner at Parker Shaffie LLP
- Scott Cooper Miami Project Announces New Scholarship Winner: Aban Khan
- California: Governor Newsom Announces Judicial Appointments 12.7.23
- RH Reports Third Quarter 2023 Results
- Incandescent Entertainment Announces New Film, "Portal in the Pines," starring Jamie Kennedy to Begin Filming This Month in Lousiana
- Tella Firma Foundations Partners with Green Clean Solar to Increase Steel Recycling in the Renewable Energy Industry
- What California Accomplished at COP28
- California Humanitarian Aid Arrives to Help Civilians in Israel and Gaza
- Feature film about President Trump's response to the pandemic and the 2020 election – streaming now
- Kaiser Permanente Donates $10,000 To SEEAG's Ag-Education Programs
- Long Beach Pledge Guaranteed Income Pilot Program to Expand with Second Cohort
- Refurbishing Cryostats with IMEB Inc.'s Laboratory Techs and Its Benefits